Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP206443.RAfysQ6NjtoYPmJ1VqQSD6Sp345we3LtIr9ujZVsPHscA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP206443.RAfysQ6NjtoYPmJ1VqQSD6Sp345we3LtIr9ujZVsPHscA130_assertion type Assertion NP206443.RAfysQ6NjtoYPmJ1VqQSD6Sp345we3LtIr9ujZVsPHscA130_head.
- NP206443.RAfysQ6NjtoYPmJ1VqQSD6Sp345we3LtIr9ujZVsPHscA130_assertion wasGeneratedBy ECO_0000203 NP206443.RAfysQ6NjtoYPmJ1VqQSD6Sp345we3LtIr9ujZVsPHscA130_provenance.
- NP206443.RAfysQ6NjtoYPmJ1VqQSD6Sp345we3LtIr9ujZVsPHscA130_assertion wasDerivedFrom befree-20140225 NP206443.RAfysQ6NjtoYPmJ1VqQSD6Sp345we3LtIr9ujZVsPHscA130_provenance.
- NP206443.RAfysQ6NjtoYPmJ1VqQSD6Sp345we3LtIr9ujZVsPHscA130_assertion SIO_000772 16126332 NP206443.RAfysQ6NjtoYPmJ1VqQSD6Sp345we3LtIr9ujZVsPHscA130_provenance.
- NP206443.RAfysQ6NjtoYPmJ1VqQSD6Sp345we3LtIr9ujZVsPHscA130_assertion evidence source_evidence_literature NP206443.RAfysQ6NjtoYPmJ1VqQSD6Sp345we3LtIr9ujZVsPHscA130_provenance.
- NP206443.RAfysQ6NjtoYPmJ1VqQSD6Sp345we3LtIr9ujZVsPHscA130_assertion description "[The Val158Met polymorphism of COMT is associated with the PSA-progression-free rate of EMP-treated patients in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP206443.RAfysQ6NjtoYPmJ1VqQSD6Sp345we3LtIr9ujZVsPHscA130_provenance.